Galectin-8 expression in laryngeal squamous cell carcinoma

Clinical and Experimental Otorhinolaryngology

Volumn 2, Issue 1, 2009, Pages 13-19

  Dong, Geun Woo ^a   Kim, Jun ^a   Park, Jun Hee ^b   Choi, Ji Yun ^a   Cho, Sung Il ^a,b   Lim, Sung Chul ^a  

^a Departments of Otorhinolaryngology Head and Neck Surgery   (South Korea)

^b Chosun University College of Medicine   (South Korea)

Author keywords

Galectin 8; Immunohistochemistry; Larynx; Squamous cell carcinoma

Indexed keywords

EID: 68249098964     PISSN: 19768710     EISSN: 20050720     Source Type: Journal    
DOI: 10.3342/ceo.2009.2.1.13     Document Type: Article

References (33)

1. Schantz SP, Hanison LB, Forastiere AA. Tumors of the nasal cavity and paranasal sinuses, nasopharynx, oral cavity, and oropharynx. In: DeVita V., Hellman S., Rosenberg S., editors. Cancer: principles and practice of oncology. 5th ed. Philadelphia (PA): JB Lippincott; 1997. p. 741-847.
2. Park IS, Kim SH, Jung YG, Rho YS, Kim HJ, Lira HJ. Clinical significance of the expression of TGF-a and TGF-β in squamous cell carcinoma of the larynx and hypopharynx. Korean J Otolaryngol-Head Neck Surg. 1996 Jun;39(6):980-9.
3. Hadari YR, Paz K., Dekel R., Mestrovic T., Accili D., Zick Y. Galectin-8: a new rat lectin, related to galectin-4. J Biol Chem. 1995 Feb. 17;270(7): 3447-53.
4. Hadari YR, Eisenstein M., Zakut R., Zick Y. Galectin-8: on the road from structure to function. Trends Glycosci Glycotechnol. 1997 Jan;9(45): 103-12.
5. Hadari YR, Arbel-Goren R., Levy Y., Amsterdam A., Alon R., Zakut R., et al. Galectin-8 binding to integrins inhibits cell adhesion and induces apoptosis. J Cell Sci. 2000 Jul;113 (Pt 13):2385-97.
6. Zick Y., Eisenstein M., Goren RA, Hadari YR, Levy Y., Ronen D. Role of galectin-8 as a modulator of cell adhesion and cell growth. Glycoconj J. 2004;19 (7-9):517-26.
7. Shin DH, Lee CH, Kang HJ, Sol MY, Lee MK Significance of galectin-3 expression in pulmonary non-small cell carcinoma. Korean J Pathol. 2006 Oct;40(5):326-32.
8. Kim HJ, Kim KH, Jang YD, Cho SH, Koh YW, Kim DW, et al. The expression of vascular endothelial growth factor (VEGF) and survivin in squamous cell carcinoma of larynx. Korean J Otolaryngol-Head Neck Surg. 2006 Dec;49(12):1188-93.
9. Jung KY, Choi JO. Clinical significance of the expression of oncosuppressor gene protein and epidermal growth factor receptor in squamous cell carcinoma of the larynx. Korean J Otolaryngol-Head Neck Surg. 1993;36(5):990-1004.
10. Lee DY, Im DM, Do NY, Na HJ, Choi JS, Kim SH, et al. Study on immunohistochemical expression of p53, epidermal growth factor and cerbB-2 in squamous cell carcinoma of the head and neck. Korean J Otolaryngol-Head Neck Surg. 2001 Apr;44(4):412-47.
11. Barondes SH, Castronovo V., Cooper DN, Cummings RD, Drickamer K., Feizi T., et al. Galectins: a family of animal beta-galactoside-binding lectins. Cell. 1994 Feb. 25;76(4):597-8.
12. Hirabayashi J., Hashidate T., Arata Y., Nishi N., Nakamura T., Hirashima M., et al. Oligosaccharide specificity of galectins: a search by frontal affinity chromatography. Biochim Biophys Acta. 2002 Sep;1572 (2-3): 232-54.
13. Leffler H. Introduction to galectins. Trends Glycosci Glycotechnol. 1997 Jan;9(45):9-19.
14. Hirabayashi J., Kasai K. The family of metazoan metal-independent β-galactoside-binding lectins: structure, function and molecular evolution. Glycobiology. 1993 Aug;3(4):297-304.
15. Liu FT, Patterson RJ, Wang JL. Intracellular functions of galectins. Biochim Biophys Acta. 2002 Sep. 19;1572 (2-3):263-73.
16. Perillo NL, Marcus ME, Baum LG. Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death. J Mol Med. 1998 May; 76(6):402-12.
17. Danguy A., Camby I., Kiss R. Galectins and cancer. Biochim Biophys Acta. 2002 Sep. 19;1572 (2-3):285-93.
18. Haugen BR, Woodmansee WW, McDermott MT. Towards improving the utility of fine-needle aspiration biopsy for the diagnosis of thyroid tumours. Clin Endocrinol (Oxf). 2002 Mar;56(3):281-90.
19. Bidon-Wagner N., Le Pennec JP. Human galectin-8 isoforms and cancer. Glycoconj J. 2004;19 (7-9):557-63.
20. Rechreche H., Mallo GV, Montalto G., Dagorn JC, Iovanna JL. Cloning and expression of the mRNA of human galectin-4, an S-type lectin downregulated in colorectal cancer. Eur J Biochem. 1997 Aug. 15;248(1): 225-30.
21. Nagy N., Legendre H., Engels O., Andre S., Kaltner H., Wasano K., et al. Refined prognostic evaluation in colon carcinoma using immunohistochemical galectin fingerprinting. Cancer. 2003 Apr. 15;97(8):1849-58.
22. Levy Y., Arbel-Goren R., Hadari YR, Eshhar S., Ronen D., Elhanany E., et al. Galectin-8 functions as a matricellular modulator of cell adhesion. J Biol Chem. 2001 Aug. 17;276(33):31285-95.
23. Bidon N., Brichory F., Bourguet P., Le Pennec JP, Dazord L. Galectin-8: a complex sub-family of galectins (Review). Int J Mol Med. 2001 Sep;8(3):245-50.
24. Danguy A., Rorive S., Decaestecker C., Bronckart Y., Kaltner H., Hadari YR, et al. Immunohistochemical profile of galectin-8 expression in benign and malignant tumors of epithelial, mesenchymatous and adipous origins, and of the nervous system. Histol Histopathol. 2001 Jul;16(3): 861-8.
25. Nagy N., Bronckart Y., Camby I., Legendre H., Lahm H., Kaltner H., et al. Galectin-8 expression decreases in cancer compared with normal and dysplastic human colon tissue and acts significantly on human colon cancer cell migration as a suppressor. Gut. 2002 Mar;50(3):392-401.
26. Camby I., Belot N., Rorive S., Lefranc F., Maurage CA, Lahm H., et al. Galectins are differentially expressed in supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas, and significantly modulate tumor astrocyte migration. Brain Pathol. 2001 Jan;ll (1):12-26.
27. Bidon N., Brichory F., Hanash S., Bourguet P., Dazord L., Le Pennec JP. Two messenger RNAs and five isoforms for P066-CBP, a galectin-8 homolog in a human lung carcinoma cell line. Gene. 2001 Aug. 22;274 (1-2):253-62.
28. Bassen R., Brichory F., Caulet-Maugendre S., Bidon N., Delaval P., Desrues B., et al. Expression of P066-CBP, a type-8 galectin, in different healthy, tumoral and peritumoral tissues. Anticancer Res. 1999 Nov-Dec;19 (6B): 5429-33.
29. Henno S., Brichory F., Langanay T., Desrues B., Bidon N., Delaval P., et al. Expression of P066-CBP, a galectin-8, in different types of primary and secondary broncho-pulmonary tumors. Oncol Rep. 2002 Jan-Feb; 9 (1):177-80.
30. Caulet-Maugendre S., Birolleau S., Corbineau H., Bassen R., Desrues B., Bidon N., et al. Immunohistochemical expression of the intracellular component of galectin-8 in squamous cell metaplasia of the bronchial epithelium in neoplastic and benign processes. Pathol Res Pract 2001; 197(12):797-801.
31. Su ZZ, Lin J., Shen R., Fisher PE, Goldstein NI, Fisher PB. Surface-epitope masking and expression cloning identifies the human prostate carcinoma tumor antigen gene PCTA-1 a member of the galectin gene family. Proc Natl Acad Sci USA. 1996 Jul. 9;93(14):7252-7.
32. Wollina U., Graefe T., Feldrappe S., Andre S., Wasano K., Kaltner H., et al. Galectin fingerprinting by immuno- and lectin histochemistry in cutaneous lymphoma. J Cancer Res Clin Oncol. 2002 Feb;128(2):103-10.
33. Simon P., Decaestecker C., Choufani G., Delbrouck C., Danguy A., Salmon I., et al. The levels of retinoid RARbeta receptors correlate with galectin-1, -3 and -8 expression in human cholesteatomas. Hear Res. 2001 Jun; 156 (1-2):1-9.